Symptomatic and neuroprotective properties of adenosine A2A receptor antagonists in animal models of parkinsonism

被引:0
|
作者
Jadwiga Wardas
机构
[1] Polish Academy of Sciences,Department of Neuropsychopharmacology, Institute of Pharmacology
来源
Pharmacological Reports | 2010年 / 62卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:33 / 34
页数:1
相关论文
共 50 条
  • [31] Discovery of 2-aminoimidazopyridine adenosine A2A receptor antagonists
    McGuinness, Brian F.
    Cole, Andrew G.
    Dong, Guizhen
    Brescia, Marc-Raleigh
    Shao, Yuefei
    Henderson, Ian
    Rokosz, Laura L.
    Stauffer, Tara M.
    Mannava, Neelima
    Kimble, Earl F.
    Hicks, Catherine
    White, Nicole
    Wines, Pamela G.
    Quadros, Elizabeth
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6845 - 6849
  • [32] Potential of adenosine A2A receptor antagonists in the treatment of movement disorders
    Mally, J
    Stone, TW
    CNS DRUGS, 1998, 10 (05) : 311 - 320
  • [33] Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists
    Zhou, Gang
    Aslanian, Robert
    Gallo, Gioconda
    Khan, Tanweer
    Kuang, Rongze
    Purakkattle, Biju
    De Ruiz, Manuel
    Stamford, Andrew
    Ting, Pauline
    Wu, Heping
    Wang, Hongwu
    Xiao, Dong
    Yu, Tao
    Zhang, Yonglian
    Mullins, Deborra
    Hodgson, Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (04) : 1348 - 1354
  • [34] Adenosine A2A receptor antagonists in the therapy of Parkinson's disease
    Morelli, M.
    Simola, N.
    Pinna, A.
    Pontis, S.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 537 - 537
  • [35] Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists
    Vu, CB
    Shields, P
    Peng, B
    Kumaravel, G
    Jin, XW
    Phadke, D
    Wang, J
    Engber, T
    Ayyub, E
    Petter, RC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (19) : 4835 - 4838
  • [36] Computational studies of the binding modes of A2A adenosine receptor antagonists
    Y. Ye
    J. Wei
    X. Dai
    Q. Gao
    Amino Acids, 2008, 35 : 389 - 396
  • [37] Recent advances in the design and optimization of adenosine A2A receptor antagonists
    Vu, CB
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (04) : 458 - 468
  • [38] Computational studies of the binding modes of A2A adenosine receptor antagonists
    Ye, Y.
    Wei, J.
    Dai, X.
    Gao, Q.
    AMINO ACIDS, 2008, 35 (02) : 389 - 396
  • [39] Evaluation of analogues of (-)-mefloquine as adenosine A2A receptor antagonists.
    Gillespie, RJ
    Giles, PR
    Lerpiniere, J
    Ward, SE
    Weiss, SM
    Knight, TR
    Misra, A
    Benwell, K
    Dourish, CT
    Cliffe, IA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U51 - U51
  • [40] A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
    Spinaci, Andrea
    Lambertucci, Catia
    Buccioni, Michela
    Dal Ben, Diego
    Graiff, Claudia
    Barbalace, Maria Cristina
    Hrelia, Silvana
    Angeloni, Cristina
    Tayebati, Seyed Khosrow
    Ubaldi, Massimo
    Masi, Alessio
    Klotz, Karl-Norbert
    Volpini, Rosaria
    Marucci, Gabriella
    MOLECULES, 2022, 27 (08):